Nachrichten zur Apellis Pharmaceuticals Inc. Aktie

Strength Seen in Apellis Pharmaceuticals, Inc. (APLS): Can Its 16.3% Jump Turn into More Strength?

Apellis Pharmaceuticals, Inc. (APLS) witnessed a jump in share price last session on above-average trading volume. The latest trend in…

Apellis Pharmaceuticals may be worth $90-$100 a share in sale - analyst

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Blitz-Update Wall Street: S&P 500 dreht ins Plus, Nasdaq 100 dämmt Verluste ein – Apellis, Marathon Oil und Teck Resources geben Gas

Die US-Börsen haben am Montag einen uneinheitlich in den Börsenmonat April verzeichnet. Getragen von hohen Kursgewinnen bei Papieren aus der…

AKTIONÄR-Tipp Apellis steigt 17 Prozent – geht da noch mehr?

Die Aktie des US-Biotech-Unternehmens Apellis legt zum Wochenstart einen deutlichen Kurssprung hin. Auf der Handelsplattform Tradegate geht es 17 Prozent…

Apellis Pharmaceuticals sees takeover interest from large pharma - Bloomberg

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 1-Biotech firm Apellis attracts takeover interest - Bloomberg News

...(Adds details from Bloomberg report, background) April 2 (Reuters... to Refinitiv data. Apellis did not immediately respond to a Reuters request......…

Biotech firm Apellis attracts takeover interest - Bloomberg News

...(Reuters) - Biotech company Apellis Pharmaceuticals Inc has drawn..., the report added. Apellis did not immediately respond…

US Biotech Firm Apellis Is Said to Attract Takeover Interest

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Chief Executive Officer verkauft Aktien von Apellis Pharmaceuticals im Wert von 1.882.332$

Francois, Cedric - Vorstand - Tag der Transaktion: 2023-03-21...…

Why Is Apellis Pharmaceuticals, Inc. (APLS) Down 7% Since Last Earnings Report?

Apellis Pharmaceuticals, Inc. (APLS) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

S&P 500 Futures Rise in Premarket Trading; Coinbase Global, Apellis Pharmaceuticals Lag

S&P 500 Futures Rise in Premarket Trading; Coinbase Global, Apellis Pharmaceuticals Lag...…

Insiderhandel: Aufsichtsrat verkauft Aktien von Apellis Pharmaceuticals im Wert von 80.038$

Machiels, Alec - Aufsichtsrat - Tag der Transaktion: 2023-03-17...…

Form 8-K Apellis Pharmaceuticals, For: Mar 15

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Chief Scientific Officer verkauft Aktien von Apellis Pharmaceuticals im Wert von 765.480$

Deschatelets, Pascal - Vorstand - Tag der Transaktion: 2023-03-08...…

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader…

Insiderhandel: Aufsichtsrat verkauft Aktien von Apellis Pharmaceuticals im Wert von 32.665$

Dunlop, A. Sinclair - Aufsichtsrat - Tag der Transaktion: 2023-03-01...…

Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Option to Purchase Additional Shares

WALTHAM, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq: APLS), a global biopharmaceutical company and leader…

Why Apellis Pharmaceuticals Stock Surged This Week

A highly eventful five days for the company saw bulls pile into its shares....…

Form 8-K Apellis Pharmaceuticals, For: Feb 22

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Apellis Pharmaceuticals prices $350M in stock offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

WALTHAM, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq:APLS), a global biopharmaceutical company and leader in…

Thinking about trading options or stock in Wix.Com, Palo Alto Networks, Tesla, Progressive, or Apellis Pharmaceuticals?

NEW YORK, Feb. 22, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WIX, PANW, TSLA, PGR, and APLS. Click…

Apellis Pharmaceuticals to raise $300M in stock and warrants offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Loss, Tops Revenue Estimates

Apellis Pharmaceuticals, Inc. (APLS) delivered earnings and revenue surprises of 9.09% and 8.47%, respectively, for the quarter ended December 2022.…

Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results

WALTHAM, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader…

Thinking about buying stock in Apellis Pharmaceuticals, Vir Biotechnology, Actinium Pharmaceuticals, Arbe Robotics, or Sigma Lithium?

NEW YORK, Feb. 21, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APLS, VIR, ATNM, ARBE, and SGML. To…

S&P 500 Futures Fall in Premarket Trading; Apellis Pharmaceuticals, Teck Resources Lead

S&P 500 Futures Fall in Premarket Trading; Apellis Pharmaceuticals, Teck Resources Lead...…

Analysts Estimate Apellis Pharmaceuticals, Inc. (APLS) to Report a Decline in Earnings: What to Look Out for

Apellis Pharmaceuticals, Inc. (APLS) doesnt possess the right combination of the two key ingredients for a likely earnings beat in…

XFRA : 1JK: Wiederaufnahme/Resumption

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING…

Stocks to Watch: Apellis Pharmaceuticals, Sigma Lithium

Stocks to Watch: Apellis Pharmaceuticals, Sigma Lithium...…

Apellis Pharmaceuticals Shares Rise 11% on FDA Approval of Syfovre

Apellis Pharmaceuticals Shares Rise 11% on FDA Approval of Syfovre...…

Apellis wins FDA nod for eye disorder therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

XFRA : 1JK: Aussetzung/Suspension

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME …

XFRA : INSTRUMENT_SUSPENSION - US03753U1060

Instrument ID [10573] (1JK - US03753U1060) suspended...…

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader…

Insiderhandel: Chief Scientific Officer verkauft Aktien von Apellis Pharmaceuticals im Wert von 653.400$

Deschatelets, Pascal - Vorstand - Tag der Transaktion: 2023-02-08...…

Age-related macular degeneration (AMD) market size to increase by USD 4,360.68 million: Evolving Opportunities with Amgen Inc and Apellis Pharmaceuticals Inc among others - Technavio

NEW YORK, Feb. 3, 2023 /PRNewswire/ -- Technavio report provides the key offerings of 15+ vendors of the age-related macular…

dpa-AFX ProFeed